Milestone Scientific appoints Shanth Thiyagalingam as independent director

MILESTONE SCIENTIFIC INC.

Appointed on May 14, 2025 as an independent director; fills Board vacancy.
Thiyagalingam is CEO of PainTEQ, a medical device maker, with prior roles at Abbott, Nevro, Stryker, and St. Jude Medical.
Brings medical device industry and commercial leadership experience to the Board.

item 5.02 item 7.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Shanth Thiyagalingam

independent director

MLSS · MILESTONE SCIENTIFIC INC.

Effective: 2025-05-14
Filed: May 19, 2025, 7:59 PM ET

On May 14, 2025, the Board of Directors of Milestone Scientific Inc. (the “Company”) unanimously by the directors in attendance appointed Shanth Thiyagalingam as an independent director of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Shanth Thiyagalingam was appointed as independent director at MILESTONE SCIENTIFIC INC..

Action: appointed
Role: independent director

Exact text from the filing

On May 14, 2025, the Board of Directors of Milestone Scientific Inc. (the “Company”) unanimously by the directors in attendance appointed Shanth Thiyagalingam as an independent director of the Company.

View on SEC.gov

MILESTONE SCIENTIFIC INC. filing history →

Source: SEC EDGAR

accession 0001437749-25-017562

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.